Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microtubule binding	VAPA DCDC1 REEP1 MAP1B MAP2 RCC2 DST ALMS1 MID1 KIF19 GOLGA8B CEP295	3.79e-06	308	150	12	GO:0008017
GeneOntologyMolecularFunction	tubulin binding	VAPA DCDC1 REEP1 MAP1B MAP2 RCC2 DST ALMS1 MID1 KIF19 GOLGA8B CEP295	9.69e-05	428	150	12	GO:0015631
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRB PTPRG PTPRN2	2.62e-04	17	150	3	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRB PTPRG PTPRN2	2.62e-04	17	150	3	GO:0019198
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	PMS2 WAPL ATRX MLH3 CHD6 DNA2	3.98e-04	127	150	6	GO:0008094
GeneOntologyMolecularFunction	cytoskeletal regulatory protein binding	MAP1B MAP2	5.52e-04	5	150	2	GO:0005519
GeneOntologyMolecularFunction	cytoskeletal protein binding	VAPA ABRA PHACTR2 CTNNAL1 DCDC1 REEP1 MAP1B MAP2 COBLL1 EPB41L3 SHTN1 RCC2 DST ALMS1 MID1 KIF19 GOLGA8B CEP295 EPB41	5.93e-04	1099	150	19	GO:0008092
GeneOntologyCellularComponent	mitotic spindle	WAPL DCDC1 ECT2 RCC2 NGRN TPX2 GOLGA8B CEP295 EPB41	1.15e-05	201	145	9	GO:0072686
GeneOntologyCellularComponent	microtubule	DNAH3 DCDC1 REEP1 MAP1B MAP2 SHTN1 RCC2 DST MID1 KIF19 TPX2 GOLGA8B CEP295 SPAG17	2.12e-05	533	145	14	GO:0005874
Domain	MutL_C	PMS2 MLH3	6.07e-05	2	146	2	IPR014790
Domain	MutL_C	PMS2 MLH3	6.07e-05	2	146	2	PF08676
Domain	MutL_C	PMS2 MLH3	6.07e-05	2	146	2	SM00853
Domain	PTPc_motif	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	9.71e-05	59	146	5	SM00404
Domain	Tyr_Pase_cat	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	9.71e-05	59	146	5	IPR003595
Domain	PTPc	PTPN12 PTPRB PTPRG PTPRN2	1.74e-04	36	146	4	SM00194
Domain	ALMS_motif	ALMS1 CEP295	1.81e-04	3	146	2	IPR029299
Domain	ALMS_motif	ALMS1 CEP295	1.81e-04	3	146	2	PF15309
Domain	TYR_PHOSPHATASE_PTP	PTPN12 PTPRB PTPRG PTPRN2	2.38e-04	39	146	4	PS50055
Domain	Tyr_Pase_AS	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	2.67e-04	73	146	5	IPR016130
Domain	PTPase_domain	PTPN12 PTPRB PTPRG PTPRN2	2.90e-04	41	146	4	IPR000242
Domain	Y_phosphatase	PTPN12 PTPRB PTPRG PTPRN2	2.90e-04	41	146	4	PF00102
Domain	4_1_CTD	EPB41L3 EPB41	3.60e-04	4	146	2	PF05902
Domain	SAB	EPB41L3 EPB41	3.60e-04	4	146	2	PF04382
Domain	DNA_MISMATCH_REPAIR_1	PMS2 MLH3	3.60e-04	4	146	2	PS00058
Domain	DNA_mismatch_repair_C	PMS2 MLH3	3.60e-04	4	146	2	IPR013507
Domain	Band_4.1_C	EPB41L3 EPB41	3.60e-04	4	146	2	IPR008379
Domain	SAB_dom	EPB41L3 EPB41	3.60e-04	4	146	2	IPR007477
Domain	DNA_mismatch_repair_fam	PMS2 MLH3	3.60e-04	4	146	2	IPR002099
Domain	DNA_mis_repair	PMS2 MLH3	3.60e-04	4	146	2	PF01119
Domain	TYR_PHOSPHATASE_1	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	5.71e-04	86	146	5	PS00383
Domain	DNA_mismatch_repair_CS	PMS2 MLH3	5.98e-04	5	146	2	IPR014762
Domain	AWS	ASH1L NSD1	5.98e-04	5	146	2	SM00570
Domain	AWS	ASH1L NSD1	5.98e-04	5	146	2	PS51215
Domain	AWS_dom	ASH1L NSD1	5.98e-04	5	146	2	IPR006560
Domain	TYR_PHOSPHATASE_dom	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	6.02e-04	87	146	5	IPR000387
Domain	TYR_PHOSPHATASE_2	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	6.02e-04	87	146	5	PS50056
Domain	-	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	7.76e-04	92	146	5	3.90.190.10
Domain	Znf_FYVE_PHD	ATRX PCLO ASH1L NSD1 PHF21A FGD1	1.05e-03	147	146	6	IPR011011
Domain	Prot-tyrosine_phosphatase-like	DUSP1 PTPN12 PTPRB PTPRG PTPRN2	1.08e-03	99	146	5	IPR029021
Domain	-	RGPD2 GOLGA4	2.62e-03	10	146	2	1.10.220.60
Domain	RING	MKRN4P ATRX VPS8 NSD1 CUL9 RNF17 PHF21A MID1	2.78e-03	305	146	8	SM00184
Domain	Grip	RGPD2 GOLGA4	3.19e-03	11	146	2	SM00755
Domain	GRIP	RGPD2 GOLGA4	3.19e-03	11	146	2	PF01465
Domain	GRIP_dom	RGPD2 GOLGA4	3.80e-03	12	146	2	IPR000237
Domain	GRIP	RGPD2 GOLGA4	3.80e-03	12	146	2	PS50913
Domain	SET	ASH1L NSD1 KMT5B	4.01e-03	41	146	3	PF00856
Domain	Znf_RING	MKRN4P ATRX VPS8 NSD1 CUL9 RNF17 PHF21A MID1	4.16e-03	326	146	8	IPR001841
Domain	FA	EPB41L3 EPB41	4.47e-03	13	146	2	PF08736
Domain	FERM-adjacent	EPB41L3 EPB41	4.47e-03	13	146	2	IPR014847
Domain	FA	EPB41L3 EPB41	4.47e-03	13	146	2	SM01195
Domain	TUDOR	RNF17 TDRD1	5.19e-03	14	146	2	PF00567
Domain	SET	ASH1L NSD1 KMT5B	5.56e-03	46	146	3	SM00317
Domain	ZF_PHD_2	ATRX ASH1L NSD1 PHF21A	6.58e-03	95	146	4	PS50016
Domain	Post-SET_dom	ASH1L NSD1	6.78e-03	16	146	2	IPR003616
Domain	GATA_ZN_FINGER_1	ATRX GATA3	6.78e-03	16	146	2	PS00344
Domain	PostSET	ASH1L NSD1	6.78e-03	16	146	2	SM00508
Domain	GATA_ZN_FINGER_2	ATRX GATA3	6.78e-03	16	146	2	PS50114
Domain	POST_SET	ASH1L NSD1	6.78e-03	16	146	2	PS50868
Domain	ZF_PHD_1	ATRX ASH1L NSD1 PHF21A	6.83e-03	96	146	4	PS01359
Domain	SET_dom	ASH1L NSD1 KMT5B	7.01e-03	50	146	3	IPR001214
Domain	SET	ASH1L NSD1 KMT5B	7.01e-03	50	146	3	PS50280
Domain	Carb_anhydrase	PTPRG CA1	7.64e-03	17	146	2	PF00194
Domain	Carb_anhydrase	PTPRG CA1	7.64e-03	17	146	2	SM01057
Domain	-	PTPRG CA1	7.64e-03	17	146	2	3.10.200.10
Domain	ALPHA_CA_2	PTPRG CA1	7.64e-03	17	146	2	PS51144
Domain	Carbonic_anhydrase_a	PTPRG CA1	7.64e-03	17	146	2	IPR001148
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	HINT1 WAPL ATRX MAP1B ETF1 EPB41L3 SHTN1 EIF6 RCC2 PHF21A AKAP12 SLC25A3 PTPN12 DST ALMS1 UBTF TPX2 MKI67 EPB41 HERC5	6.70e-09	934	154	20	33916271
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	JCAD PHACTR2 MAP1B MAP2 COBLL1 PSD3 EPB41L3 SHTN1 ECT2 USP31 FSIP2 DST ALMS1 AASS TET1 CRYBG3 EPB41 GOLGA4 DOP1A	1.02e-08	861	154	19	36931259
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PMS2 CTNNAL1 WAPL ZNF473 ATRX ASH1L NSD1 HIPK2 ASH2L AKAP12 ZNF750 PAXBP1 UBTF VCAN TET1 TRAPPC10 CEP295 ZMYM1 POLK DNA2	7.73e-08	1084	154	20	11544199
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KANSL1L DNAH3 TBC1D8B AKAP12 DST ALMS1 MKI67 CEP295 ZNF292 PGBD2	9.92e-08	233	154	10	37704626
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	VAPA CTNNAL1 RIPK1 MAP1B COBLL1 ETF1 PSD3 EPB41L3 SHTN1 RCC2 AKAP12 SLC25A3 DST CRYBG3 EPB41 GOLGA4	1.16e-07	708	154	16	39231216
Pubmed	Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.	PDXDC1 VAPA VPS8 PSD3 CHML RCC2 AKAP12 TPX2 TMF1 EPB41 GOLGA4	3.73e-07	339	154	11	37232246
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD2 NRIP1 EPB41L3 SHTN1 PHF21A DST ALMS1 ZNF592 TET1 TMF1 CHD6 CRYBG3	4.00e-07	418	154	12	34709266
Pubmed	Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.	ASH1L KMT5B ZNF292	8.46e-07	5	154	3	28191889
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	ASH1L CCDC168 TTF1 PHF21A FSIP2 DST ZNF292	1.34e-06	123	154	7	26912792
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	PHACTR2 AFF2 CUL9 EPB41L3 TDRD1 ECT2 CDKL5 PTPRN2 TPX2 MKI67	2.31e-06	329	154	10	17474147
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	WAPL ATRX NSD1 FSIP2 TRMT6 ZNF592 UBTF KAT8 ATAD2B TPX2 MKI67 CHD6 ZNF292	3.46e-06	608	154	13	36089195
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WAPL NYAP2 RCC2 PHF21A TRMT6 DST ZNF592 TET1 PLAGL2 CEP126 FAM149B1 DNA2	4.60e-06	529	154	12	14621295
Pubmed	Identification of potential nuclear reprogramming and differentiation factors by a novel selection method for cloning chromatin-binding proteins.	MKRN4P ATRX NSD1	4.69e-06	8	154	3	15522233
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	PDXDC1 PSD3 SIRPA EPB41L3 AKAP12 SLC25A3 DST PTPRG LPCAT2 EPB41	7.66e-06	377	154	10	38117590
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ATRX ASH2L PTPN12 PAXBP1 ALMS1 ZNF592 UBTF TPX2 CHD6 TRMT1L DNA2	8.51e-06	469	154	11	27634302
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	PDXDC1 VAPA JCAD PHACTR2 COBLL1 SIRPA EPB41L3 SHTN1 CDKL5 DST GOLGA8B EPB41	8.91e-06	565	154	12	25468996
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	WAPL DCDC1 ASH1L CUL9 SREK1 EPB41L3 PHF21A NUFIP1 MLH3 ALMS1 PRPF40B KMT5B CCNB3 ZNF592 CEP295 CRYBG3 DNA2	1.00e-05	1116	154	17	31753913
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	COBLL1 NSD1 TEX15 RCC2 DST OTOF UBTF TPX2	1.05e-05	234	154	8	36243803
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	VAPA ATRX NSD1 SREK1 ECT2 TTF1 EIF6 ASH2L RCC2 SLC25A3 TRMT10C PAXBP1 DST ZNF592 KAT8 TPX2 TMF1 CHD6 TRMT1L EPB41	1.10e-05	1497	154	20	31527615
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NRIP1 WAPL MAP2 ETF1 SREK1 EPB41L3 PTPRB ZNF592 UBTF KIF19 ZNF292	1.46e-05	497	154	11	36774506
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	JCAD NRIP1 PMS2 WAPL ZNF473 ATRX ASH1L CUL9 VPS54 CMYA5 SHTN1 NUFIP1 DST OTOF ZNF592 LRRCC1 CHD6 ZNF292	1.67e-05	1285	154	18	35914814
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	JCAD PMS2 CTNNAL1 DUSP1 PSD3 USP31 TRMT10C PTPN12 PTPRB PTPRG PTPRN2 UBTF MKI67 TMF1 CRYBG3 GOLGA4	1.83e-05	1049	154	16	27880917
Pubmed	Hereditary cataract of the Nakano mouse: Involvement of a hypomorphic mutation in the coproporphyrinogen oxidase gene.	CPOX CRYBG3	1.95e-05	2	154	2	23631845
Pubmed	Genetic evidence for the involvement of mismatch repair proteins, PMS2 and MLH3, in a late step of homologous recombination.	PMS2 MLH3	1.95e-05	2	154	2	33453991
Pubmed	TET1 modulates H4K16 acetylation by controlling auto-acetylation of hMOF to affect gene regulation and DNA repair function.	KAT8 TET1	1.95e-05	2	154	2	27733505
Pubmed	The 4.1B cytoskeletal protein regulates the domain organization and sheath thickness of myelinated axons.	EPB41L3 EPB41	1.95e-05	2	154	2	23109359
Pubmed	Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction.	MAP1B DST	1.95e-05	2	154	2	22412020
Pubmed	Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.	EPB41L3 EPB41	1.95e-05	2	154	2	15731777
Pubmed	Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.	GATA3 MKI67	1.95e-05	2	154	2	19946260
Pubmed	ASH2L Aggravates Fibrosis and Inflammation through HIPK2 in High Glucose-Induced Glomerular Mesangial Cells.	HIPK2 ASH2L	1.95e-05	2	154	2	36553510
Pubmed	Gata-3 and KI-67 expression in correlation with molecular subtypes of breast cancer.	GATA3 MKI67	1.95e-05	2	154	2	34057115
Pubmed	CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization.	SHTN1 CDKL5	1.95e-05	2	154	2	26849555
Pubmed	The Relationship of GATA3 and Ki-67 With Histopathological Prognostic Parameters, Locoregional Recurrence and Disease-free Survival in Invasive Ductal Carcinoma of the Breast.	GATA3 MKI67	1.95e-05	2	154	2	32988889
Pubmed	ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.	ALMS1 CEP295	1.95e-05	2	154	2	30421101
Pubmed	Human transcription factor protein interaction networks.	VAPA ATRX GATA3 HIPK2 CUL9 EIF6 ASH2L RCC2 PHF21A DST ALMS1 ZNF592 UBTF KAT8 TPX2 MKI67 CHD6 ZMYM1 TRMT1L	1.98e-05	1429	154	19	35140242
Pubmed	Tagging genes with cassette-exchange sites.	VAPA RNF17 ECT2 ASH2L TET1 TPX2 MKI67 ZMYM1 ZNF292	2.00e-05	335	154	9	15741177
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	CUL9 EPB41L3 SHTN1 DST ALMS1 PTPRN2	2.59e-05	130	154	6	12421765
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	PMS2 MAP1B EPB41L3 SHTN1 RCC2 DST ALMS1 ZNF592 KAT8 TPX2 CHD6 EPB41	3.27e-05	645	154	12	25281560
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MAP1B NSD1 CUL9 EPB41L3 TTF1 EIF6 RCC2 DST UBTF ATAD2B MKI67 HERC5	3.69e-05	653	154	12	22586326
Pubmed	DNA dioxygenases Tet2/3 regulate gene promoter accessibility and chromatin topology in lineage-specific loci to control epithelial differentiation.	GATA3 TET1 MKI67	3.73e-05	15	154	3	36630508
Pubmed	Receptor protein tyrosine phosphatases are expressed by cycling retinal progenitor cells and involved in neuronal development of mouse retina.	MAP2 PTPRG MKI67	4.57e-05	16	154	3	18308476
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	PDXDC1 VAPA EPB41L3 CHML SHTN1 AKAP12 DST LPCAT2 TMF1 EPB41 GOLGA4	4.92e-05	568	154	11	37774976
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	RGPD2 ASH2L UBTF KAT8 TET1 TPX2	4.98e-05	146	154	6	23892456
Pubmed	Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization.	MAP1B MAP2	5.83e-05	3	154	2	11581286
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MUC16 MKI67	5.83e-05	3	154	2	27163153
Pubmed	miR-23a promotes the transition from indolent to invasive colorectal cancer.	PMS2 MLH3	5.83e-05	3	154	2	22628407
Pubmed	N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism.	PPARD TRMT6	5.83e-05	3	154	2	34728628
Pubmed	Protein 4.1 expression in the developing hair cells of the mouse inner ear.	EPB41L3 EPB41	5.83e-05	3	154	2	19853587
Pubmed	Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes.	PHF21A ZNF292	5.83e-05	3	154	2	35982159
Pubmed	MAP1B and clathrin are novel interacting partners of the giant cyto-linker dystonin.	MAP1B DST	5.83e-05	3	154	2	21936565
Pubmed	Polygenic control of the wavy coat of the NCT mouse: involvement of an intracisternal A particle insertional mutation of the protease, serine 53 (Prss53) gene, and a modifier gene.	CPOX CRYBG3	5.83e-05	3	154	2	35067752
Pubmed	The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution.	TRMT10C TRMT6	5.83e-05	3	154	2	29072297
Pubmed	Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).	GATA3 ASH2L	5.83e-05	3	154	2	25258321
Pubmed	Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.	ECT2 UBTF	5.83e-05	3	154	2	32350115
Pubmed	Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation.	RIPK1 GATA3	5.83e-05	3	154	2	25680095
Pubmed	Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731.	ALMS1 CEP295	5.83e-05	3	154	2	20844083
Pubmed	Participation of structural microtubule-associated proteins (MAPs) in the development of neuronal polarity.	MAP1B MAP2	5.83e-05	3	154	2	11891784
Pubmed	Assignment of the centromere protein H (Cenph) gene to mouse chromosome band 13D1 by in situ hybridization and interspecific backcross analyses.	MAP1B VCAN	5.83e-05	3	154	2	11060445
Pubmed	Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.	PMS2 MLH3	5.83e-05	3	154	2	16204034
Pubmed	Isoforms of protein 4.1 are differentially distributed in heart muscle cells: relation of 4.1R and 4.1G to components of the Ca2+ homeostasis system.	EPB41L3 EPB41	5.83e-05	3	154	2	22429617
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	VAPA WAPL ATRX PCLO ETF1 SREK1 CPOX CMYA5 EPB41L3 EIF6 RCC2 SLC25A3 TRMT10C TRMT6 PAXBP1 UBTF MKI67 GOLGA4	6.42e-05	1425	154	18	30948266
Pubmed	Mapping differentiation kinetics in the mouse retina reveals an extensive period of cell cycle protein expression in post-mitotic newborn neurons.	MAP1B MAP2 MKI67	6.62e-05	18	154	3	22837015
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MKRN4P ZNF473 ASH1L GATA3 PPARD PHF21A NUFIP1 ZNF750 ZNF592 UBTF PLAGL2 ZNF91 ZNF292	6.77e-05	808	154	13	20412781
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VAPA CYLC1 RGPD2 PHACTR2 ATRX MAP1B PCLO ASH1L SREK1 CPOX EPB41L3 RNF17 DST CEP295 CHD6 SPAG17 DOP1A ZNF292	7.46e-05	1442	154	18	35575683
Pubmed	ILK modulates epithelial polarity and matrix formation in hair follicles.	GATA3 VCAN MKI67	7.83e-05	19	154	3	24371086
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ABRA KANSL1L NRIP1 CMYA5 ECT2 ASH2L AKAP12 DST ALMS1 ZNF592	7.96e-05	497	154	10	23414517
Pubmed	Proteomic analysis of in vivo phosphorylated synaptic proteins.	MAP1B MAP2 PCLO EPB41L3	9.14e-05	53	154	4	15572359
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	WAPL ATRX MAP1B NSD1 SREK1 EPB41L3 RCC2 SLC25A3 PAXBP1 UBTF ATAD2B TPX2 MKI67 EPB41	9.39e-05	954	154	14	36373674
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	JCAD NYAP2 DCDC1 RCC2 PDZD4	9.85e-05	103	154	5	10819331
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NRIP1 ATRX MAP1B MAP2 ASH1L HIPK2 LMBR1 VPS54 SHTN1 TTF1 PTPRB PTPRG PTPRN2 CHD6 POLK EPB41 GOLGA4 DOP1A	1.12e-04	1489	154	18	28611215
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	DUSP1 LMBR1 MUC16 RCC2 USP31 PTPN12 PTPRB CHD6 DOP1A	1.14e-04	420	154	9	28065597
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	DNAH3 PCLO CHML ECT2 TRMT6 CCDC198 DST PTPRN2 ZNF592 ATAD2B CEP295 CHD6	1.15e-04	736	154	12	29676528
Pubmed	Screening methylation of DNA repair genes in the oral mucosa of chronic smokers.	PMS2 MLH3	1.16e-04	4	154	2	29775861
Pubmed	Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.	PMS2 MLH3	1.16e-04	4	154	2	18551179
Pubmed	Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.	GATA3 MKI67	1.16e-04	4	154	2	20484821
Pubmed	Embryonic expression of pericentrin suggests universal roles in ciliogenesis.	MAP2 MKI67	1.16e-04	4	154	2	16534625
Pubmed	An intact Pms2 ATPase domain is not essential for male fertility.	PMS2 MLH3	1.16e-04	4	154	2	26753533
Pubmed	CircASH2L facilitates tumor-like biologic behaviours and inflammation of fibroblast-like synoviocytes via miR-129-5p/HIPK2 axis in rheumatoid arthritis.	HIPK2 ASH2L	1.16e-04	4	154	2	33964939
Pubmed	Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres.	EPB41L3 EPB41	1.16e-04	4	154	2	12542678
Pubmed	CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.	MAP2 CDKL5	1.16e-04	4	154	2	18701457
Pubmed	Cardiac muscle cell cytoskeletal protein 4.1: analysis of transcripts and subcellular location--relevance to membrane integrity, microstructure, and possible role in heart failure.	EPB41L3 EPB41	1.16e-04	4	154	2	15834631
Pubmed	The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2.	PMS2 MLH3	1.16e-04	4	154	2	11292842
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	PCLO NUFIP1 PTPRB PTPRG PTPRN2 VCAN	1.19e-04	171	154	6	20201926
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	WAPL REEP1 MAP1B MAP2 EPB41L3 AKAP12 PTPN12	1.19e-04	246	154	7	15345747
Pubmed	New nomenclature for chromatin-modifying enzymes.	ASH1L NSD1 KMT5B KAT8	1.22e-04	57	154	4	18022353
Pubmed	Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.	RGPD2 MAP2 MKI67	1.23e-04	22	154	3	27717094
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	RIPK1 ATRX ASH1L NSD1 SLC25A3 KMT5B ZNF592 UBTF TPX2 MKI67	1.41e-04	533	154	10	30554943
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	VAPA JCAD RGPD2 NYAP2 REEP1 MAP1B MAP2 PCLO PSD3 EPB41L3 CDKL5 TRMT10C CRYBG3 SLC16A7 EPB41	1.73e-04	1139	154	15	36417873
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	WAPL MAP1B NSD1 SHTN1 ASH2L SLC25A3 ALMS1 TET1 TPX2 EPB41	1.79e-04	549	154	10	38280479
Pubmed	Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells.	SDC2 EPB41	1.93e-04	5	154	2	9660868
Pubmed	RNF17, a component of the mammalian germ cell nuage, is essential for spermiogenesis.	RNF17 TDRD1	1.93e-04	5	154	2	16093322
Pubmed	Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain.	MAP2 VCAN	1.93e-04	5	154	2	9716537
Pubmed	Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly.	ATRX MKI67	1.93e-04	5	154	2	23892236
Pubmed	Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain.	PTPRB PTPRG	1.93e-04	5	154	2	2169617
Pubmed	Reversible acetylation of the chromatin remodelling complex NoRC is required for non-coding RNA-dependent silencing.	TTF1 KAT8	1.93e-04	5	154	2	19578370
Pubmed	Surface expression of GluR-D AMPA receptor is dependent on an interaction between its C-terminal domain and a 4.1 protein.	EPB41L3 EPB41	1.93e-04	5	154	2	12574408
Pubmed	Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation.	ASH1L NSD1	1.93e-04	5	154	2	39390582
Pubmed	Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development.	VCAN MKI67	1.93e-04	5	154	2	22692047
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	VAPA ETF1 SREK1 EPB41L3 RCC2 PAXBP1 UBTF	2.07e-04	269	154	7	29511261
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	VAPA ATRX NSD1 TTF1 EIF6 ASH2L RCC2 PHF21A SLC25A3 PAXBP1 DST UBTF KAT8 TPX2 MKI67 CHD6	2.13e-04	1294	154	16	30804502
Interaction	NUP43 interactions	ASH1L NSD1 CCDC168 SREK1 TTF1 RCC2 PHF21A RTL4 FSIP2 PAXBP1 DST ZNF592 UBTF KAT8 ATAD2B MKI67 CHD6 ZMYM1 TRMT1L ZNF292	3.76e-08	625	149	20	int:NUP43
Interaction	KCNA3 interactions	VAPA NRIP1 CTNNAL1 AFF2 RIPK1 MAP1B COBLL1 ETF1 PSD3 EPB41L3 SHTN1 RCC2 AKAP12 SLC25A3 DST UBTF MID1 CRYBG3 EPB41 GOLGA4 DOP1A	1.80e-06	871	149	21	int:KCNA3
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRB PTPRG PTPRN2	1.34e-04	21	87	3	813
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L3 EPB41	1.36e-04	4	87	2	951
GeneFamily	MutL homologs	PMS2 MLH3	1.36e-04	4	87	2	1027
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 CMYA5 AKAP12	3.59e-04	29	87	3	396
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	ASH1L NSD1 KMT5B	5.78e-04	34	87	3	487
GeneFamily	PHD finger proteins	ASH1L NSD1 ASH2L PHF21A	9.33e-04	90	87	4	88
GeneFamily	Fibronectin type III domain containing	CMYA5 IGSF22 PTPRB PTPRG MID1	1.05e-03	160	87	5	555
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	NRIP1 CTNNAL1 HIPK2 SREK1 EPB41L3 SHTN1 ECT2 TRMT10C MID1 MKI67 ETAA1 TMF1 ZMYM1 POLK SLC16A7 GOLGA4	1.45e-06	656	152	16	M18979
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	PHACTR2 MAP2 DUSP1 COBLL1 PSD3 VPS54 CMYA5 CDKL5 PTPN12 LPCAT2 AASS MID1 EPB41 GOLGA4	1.52e-06	504	152	14	M2157
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	KANSL1L PCLO ASH1L SREK1 EPB41L3 CCDC198 PTPRG ZNF804B GOLGA4	6.05e-06	221	152	9	M39222
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	PHACTR2 ATRX ASH1L HIPK2 SREK1 VCAN	6.76e-06	79	152	6	M7102
Coexpression	GABRIELY_MIR21_TARGETS	PHACTR2 ATRX COBLL1 LMBR1 VPS54 SREK1 ATAD2B TET1 GOLGA4 ZNF292	7.69e-06	289	152	10	M2196
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	DUSP1 GATA3 PSD3 HIPK2 AKAP12 DST PTPRG PIP5K1B	9.46e-06	177	152	8	M39245
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NRIP1 WAPL ATRX MAP1B DUSP1 PHF21A PTPN12 DST ATAD2B MID1 GOLGA4 ZNF292	1.86e-05	466	152	12	M13522
Coexpression	CAMP_UP.V1_DN	HINT1 MAP2 PCLO LMBR1 EPB41L3 AKAP12 DST UBTF	2.21e-05	199	152	8	M2719
Coexpression	TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL	DUSP1 ETF1 HIPK2 SIRPA PPARD EPB41L3 SHTN1 AKAP12 TRMT6 PTPN12 LPCAT2 VCAN SDC2	3.35e-05	577	152	13	M41697
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NRIP1 WAPL ATRX MAP1B DUSP1 PSD3 PHF21A AZIN1 PTPN12 DST ATAD2B MID1 CRYBG3 SLC16A7 GOLGA4 ZNF292	3.98e-05	856	152	16	M4500
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	VAPA RGPD2 VPS8 PSD3 PPARD RNF17 TDRD1 CCDC7 LPCAT2 PTPRN2 TMEM132D TET1 SLC16A7 CA1 HERC5 DOP1A	5.02e-05	873	152	16	M16009
Coexpression	RAO_BOUND_BY_SALL4_ISOFORM_B	HINT1 WAPL PCLO ETF1 SLC25A3 FAM204A PTPN12 MLH3 DST ALMS1 VCAN LRRCC1	6.03e-05	526	152	12	M2520
Coexpression	VILLANUEVA_LIVER_CANCER_KRT19_UP	ECT2 TRMT6 ALMS1 TPX2 MKI67 DNA2 ZNF292	7.52e-05	175	152	7	M336
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	SYCP2L AFF2 REEP1 ATRX MAP1B MAP2 PCLO GATA3 SHTN1 FSIP2 VCAN GOLGA8B CEP126 SPAG17 EPB41 CA1 DOP1A PDZD4	7.74e-05	1106	152	18	M39071
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	PDXDC1 RGPD2 NRIP1 PHACTR2 HINT1 GATA3 NGRN ATAD2B TRAPPC10 GOLGA8B SLC16A7	1.06e-04	474	152	11	M40991
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL	CTNNAL1 ECT2 AASS TET1 MID1 TPX2 MKI67 PIP5K1B SDC2	1.15e-04	322	152	9	M39060
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	SYCP2L WAPL AFF2 REEP1 ATRX MAP1B MAP2 GIN1 NSD1 HIPK2 E2F7 LMBR1 SREK1 CHML TTF1 TRMT10C TRMT6 PTPN12 ALMS1 ATAD2B TET1 MID1 TPX2 MKI67 ETAA1 LRRCC1 CEP295 CEP126 FAM149B1 DNA2 EPB41 ZNF292	4.29e-09	1459	147	32	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	BCL2L14 SYCP2L WAPL AFF2 REEP1 ATRX MAP1B MAP2 GIN1 GATA3 HIPK2 E2F7 TDRD1 ECT2 TTF1 CDKL5 ALMS1 ATAD2B MID1 TPX2 MKI67 C3orf70 LRRCC1 CEP295 ZMYM1 CEP126 ZNF91 DNA2 EPB41 ZNF292	3.05e-08	1414	147	30	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	WAPL REEP1 ATRX MAP1B GIN1 HIPK2 E2F7 TDRD1 ECT2 TTF1 CDKL5 ALMS1 ATAD2B MID1 TPX2 MKI67 C3orf70 LRRCC1 CEP295 ZMYM1 CEP126 ZNF91 DNA2 EPB41 ZNF292	7.10e-08	1060	147	25	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	WAPL REEP1 ATRX GIN1 NSD1 HIPK2 E2F7 SREK1 CHML TTF1 TRMT10C TRMT6 PTPN12 ALMS1 ATAD2B TET1 MID1 TPX2 MKI67 ETAA1 LRRCC1 CEP295 CEP126 FAM149B1 DNA2 EPB41 ZNF292	1.32e-07	1257	147	27	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	KANSL1L SYCP2L AFF2 ATRX GIN1 NSD1 HIPK2 SREK1 TDRD1 SLC25A3 TRMT10C ALMS1 VCAN ATAD2B MID1 TPX2 MKI67 ETAA1 LRRCC1 TMF1 CEP295 ZMYM1 CEP126 DNA2 EPB41 ZNF292	3.79e-07	1241	147	26	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	KANSL1L WAPL ATRX MAP2 NSD1 HIPK2 SREK1 TRMT10C TRMT6 PTPN12 ALMS1 VCAN ATAD2B TET1 MID1 TPX2 MKI67 ETAA1 LRRCC1 CEP295 ZMYM1 CEP126 ZNF91 DNA2 EPB41 ZNF292	4.48e-07	1252	147	26	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	WAPL MAP1B PCLO DST ALMS1 TET1 LRRCC1 TMF1 PLAGL2 TRMT1L EPB41	1.97e-06	259	147	11	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	KANSL1L SYCP2L AFF2 ATRX GIN1 NSD1 HIPK2 LMBR1 SREK1 TDRD1 SLC25A3 TRMT10C ALMS1 VCAN ATAD2B MID1 TPX2 MKI67 ETAA1 LRRCC1 TMF1 CEP295 ZMYM1 CEP126 DNA2 EPB41 ZNF292	2.70e-06	1468	147	27	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	WAPL ATRX E2F7 DST ALMS1 TET1 TPX2 ETAA1 LRRCC1 TMF1 TRMT1L CEP126 EPB41 ZNF292	4.97e-06	469	147	14	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SYCP2L AFF2 REEP1 ATRX MAP1B MAP2 DUSP1 PCLO PSD3 HIPK2 CHML SHTN1 NGRN ALMS1 ATAD2B TPX2 LRRCC1 CEP126 EPB41 ZNF292	1.57e-05	986	147	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	WAPL REEP1 MAP1B PCLO E2F7 PTPN12 ALMS1 TPX2 ETAA1 TMF1 PLAGL2 TRMT1L CEP126 EPB41	2.05e-05	532	147	14	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	AFF2 ATRX GIN1 ASH1L HIPK2 ATAD2B TPX2 MKI67 ZNF91 EPB41	3.65e-05	291	147	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	WAPL GIN1 ALMS1 ATAD2B MKI67 LRRCC1 TMF1 EPB41	4.71e-05	186	147	8	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SYCP2L REEP1 ATRX MAP1B MAP2 GIN1 PCLO ETF1 GATA3 ECT2 TRMT6 ALMS1 ATAD2B TPX2 MKI67 C3orf70 CEP295 GOLGA4 ZNF292	5.44e-05	989	147	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200	NRIP1 ATRX ASH1L TET1 CEP295	6.47e-05	61	147	5	gudmap_developingGonad_e12.5_epididymis_k2_200
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	AFF2 REEP1 ATRX MAP1B MAP2 PSD3 NSD1 HIPK2 E2F7 VPS54 CHML ECT2 CDKL5 ALMS1 PRPF40B TPX2 MKI67 ETAA1 LRRCC1 PLAGL2 CEP295 CEP126 EPB41	6.82e-05	1370	147	23	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000	PHACTR2 MAP1B HIPK2 EPB41L3 USP31 VCAN	7.33e-05	101	147	6	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	NRIP1 PMS2 REEP1 ZNF473 ATRX ASH1L HEMGN TEX15 RNF17 ECT2 FAM204A BNC1 PTPN12 ALMS1 CCNB3 CEP295	9.79e-05	776	147	16	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	VAPA ATRX MAP1B MAP2 ASH1L NSD1 EPB41L3 USP31 PTPRG VCAN	1.04e-04	330	147	10	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2	BCL2L14 PHACTR2 DUSP1 HIPK2 SHTN1 PTPRB ALMS1 LPCAT2 TPX2 MKI67 DNA2	1.35e-04	409	147	11	GSM538234_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	SYCP2L REEP1 MAP1B MAP2 GIN1 PCLO CHML SHTN1 ALMS1 ATAD2B MID1 TPX2 LRRCC1 TMF1 CHD6 DNA2 EPB41 DOP1A	1.58e-04	983	147	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	REEP1 ATRX MAP1B GIN1 PCLO ASH1L ALMS1 TPX2 MKI67 C3orf70 FGD1 CEP295 FAM149B1 ZNF91 GOLGA4 ZNF292	2.14e-04	831	147	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	ATRX GIN1 ALMS1 ATAD2B TPX2 MKI67 CEP295 GOLGA4 ZNF292	3.25e-04	311	147	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000	BCL2L14 NRIP1 CTNNAL1 MAP1B GATA3 HIPK2 EPB41L3 SHTN1 RNF17 USP31 ZNF750 DST PLAGL2 SLC16A7 ZNF292	3.44e-04	780	147	15	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	NRIP1 REEP1 ATRX ASH1L HEMGN TEX15 RNF17 BNC1 CCNB3 CEP295	3.74e-04	387	147	10	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	HIPK2 EPB41L3 USP31 PTPRG VCAN	3.86e-04	89	147	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_500	BCL2L14 CTNNAL1 MAP1B GATA3 SHTN1 USP31 DST PLAGL2 SLC16A7 ZNF292	4.06e-04	391	147	10	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000	BCL2L14 NRIP1 CTNNAL1 MAP1B DUSP1 GATA3 HIPK2 SHTN1 RCC2 USP31 BNC1 ZNF750 DST AASS PLAGL2	4.48e-04	800	147	15	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	KANSL1L AFF2 REEP1 ATRX MAP2 PSD3 EPB41L3 TBC1D8B PHF21A CDKL5 DST VCAN TET1 C3orf70 LRRCC1 SLC16A7 SDC2 DOP1A PDZD4	4.49e-04	1166	147	19	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	REEP1 MAP1B MAP2 DUSP1 PCLO PSD3 HIPK2 CHML SHTN1 TBC1D8B TTF1 NGRN DST ALMS1 TPX2 CHD6	4.73e-04	893	147	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	NRIP1 ATRX ASH1L HEMGN RNF17 ECT2 UBTF TET1 MID1 CEP295	5.13e-04	403	147	10	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000	SYCP2L CTNNAL1 WAPL MAP1B MAP2 COBLL1 PCLO SHTN1 AZIN1 DST ALMS1 TET1 LRRCC1 TMF1 PLAGL2 TRMT1L EPB41	5.32e-04	994	147	17	Facebase_RNAseq_e8.5_Floor Plate_1000
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	KANSL1L COBLL1 SIRPA ECT2 LPCAT2 TET1 MKI67 PIP5K1B ABCD2 SLC16A7	5.33e-04	405	147	10	GSM538343_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	ATRX MAP1B ASH1L SREK1 USP31 PAXBP1 PTPRG ZNF292	5.43e-04	266	147	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500	SYCP2L CTNNAL1 AFF2 REEP1 MAP1B MAP2 PCLO SHTN1 ECT2 NGRN ATAD2B	5.45e-04	482	147	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1	PHACTR2 CTNNAL1 PSD3 SIRPA DST TET1 MKI67 LRRCC1 PIP5K1B CA1	5.75e-04	409	147	10	GSM476663_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	WAPL AFF2 GIN1 PSD3 ALMS1 ATAD2B TMF1 EPB41	6.14e-04	271	147	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	NRIP1 ATRX ASH1L TET1 MID1 CEP295	6.27e-04	150	147	6	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	REEP1 MAP1B GIN1 PCLO TBC1D8B TTF1 PHF21A DST ALMS1 TPX2 TMF1 CHD6 DOP1A	6.36e-04	654	147	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	alpha beta T cells, preT.ETP.Th, Lin-/lo CD25- CD44+ cKit+, Thymus, avg-3	DUSP1 GATA3 EPB41L3 RCC2 LAX1 LPCAT2 TET1 TPX2 PIP5K1B SLC16A7	6.44e-04	415	147	10	GSM854335_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	VAPA MAP1B HIPK2 EPB41L3 USP31 PTPRG VCAN	6.44e-04	209	147	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	SYCP2L WAPL AFF2 GIN1 GATA3 ALMS1 ATAD2B MKI67 LRRCC1 TMF1 EPB41	6.46e-04	492	147	11	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	SYCP2L AFF2 MAP1B MAP2 DUSP1 PCLO PSD3 HIPK2 CHML SHTN1 NGRN	6.90e-04	496	147	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	SYCP2L REEP1 ATRX MAP1B MAP2 PCLO ALMS1 TPX2 C3orf70 CEP295 GOLGA4	7.13e-04	498	147	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200	ATRX ASH1L HEMGN TEX15 RNF17 CCNB3	7.45e-04	155	147	6	gudmap_developingGonad_e16.5_ovary_200
CoexpressionAtlas	alpha beta T cells, preT.ETP-2A.Th, Lin-/lo CD25int CD44+ cKit+, Thymus, avg-2	KANSL1L DUSP1 GATA3 RCC2 LPCAT2 TET1 MID1 TPX2 PIP5K1B SLC16A7	7.86e-04	426	147	10	GSM791152_500
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 DCDC1 ZNF473 E2F7 LRGUK LRRIQ1 KIF19 CEP126 SPAG17 WDR49	8.05e-10	181	154	10	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DCDC1 MUC16 TDRD1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	7.98e-09	169	154	9	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DCDC1 MUC16 LRGUK LRRIQ1 KIF19 CEP126 SPAG17 WDR49	2.64e-08	194	154	9	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MAP1B PCLO ASH1L NSD1 EPB41L3 DST PTPRN2 GOLGA4	2.76e-08	195	154	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	NRIP1 PHACTR2 ATRX HIPK2 EIF6 LRRIQ1 LRRCC1 TMF1 GOLGA4	3.15e-08	198	154	9	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	NRIP1 CTNNAL1 ATRX GATA3 EIF6 AKAP12 TMF1 GOLGA4 ZNF292	3.29e-08	199	154	9	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	NRIP1 PHACTR2 ATRX GATA3 HIPK2 EIF6 TMF1 GOLGA4 ZNF292	3.29e-08	199	154	9	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATRX ASH1L SREK1 PAXBP1 ATAD2B EPB41 GOLGA4 HERC5 ZNF292	3.43e-08	200	154	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L COBLL1 GATA3 CMYA5 CCDC198 LPCAT2 MID1 SPAG17	1.44e-07	170	154	8	928e42c51a7079c506f21c669c4e4c1a0df84d77
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	REEP1 PSD3 PPARD ASH2L PTPRG C3orf70 CRYBG3 ABCD2	2.13e-07	179	154	8	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 DCDC1 MUC16 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	2.75e-07	185	154	8	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DCDC1 MAP1B LRGUK LRRIQ1 KIF19 SPAG17 WDR49	2.75e-07	185	154	8	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 DCDC1 MAP1B LRRIQ1 KIF19 CEP126 SPAG17 WDR49	3.36e-07	190	154	8	a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 WAPL ATRX ASH1L KMT5B UBTF TMF1 GOLGA4	3.50e-07	191	154	8	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 DCDC1 MUC16 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	3.50e-07	191	154	8	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 DCDC1 MUC16 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	3.50e-07	191	154	8	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 DCDC1 MUC16 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	3.50e-07	191	154	8	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PHACTR2 CTNNAL1 NYAP2 COBLL1 TTF1 CCDC7 PIP5K1B SDC2	3.64e-07	192	154	8	0b954a4e5857dac45d97c491af9b27cb2d1bd339
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COBLL1 PCLO SHTN1 LRRIQ1 TMEM132D ZNF804B PIP5K1B WDR49	3.64e-07	192	154	8	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MAP1B PCLO ASH1L EPB41L3 DST PTPRN2 GOLGA4	4.10e-07	195	154	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DCDC1 MUC16 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	4.10e-07	195	154	8	79dc031258579ea328181dda33710dd897f1064a
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL AFF2 RIPK1 ATRX MAP1B ASH1L CMYA5 SDC2	4.10e-07	195	154	8	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	(2)_B_cell-(24)_B_cell_cycling\|(2)_B_cell / shred on Cell_type and subtype	AFF2 ATRX E2F7 ECT2 TPX2 MKI67 DNA2 SDC2	4.78e-07	199	154	8	d5a9a8a71c4de8cbcef947943f60838731bc640b
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	NRIP1 ATRX HIPK2 EIF6 LRRIQ1 TMF1 GOLGA4 ZNF292	4.78e-07	199	154	8	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PHACTR2 ATRX MAP1B PCLO EIF6 DST GOLGA4 ZNF292	4.78e-07	199	154	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	CTNNAL1 ATRX GATA3 EIF6 AKAP12 TMF1 GOLGA4 ZNF292	4.78e-07	199	154	8	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATRX ASH1L SREK1 ATAD2B GOLGA8B EPB41 GOLGA4 ZNF292	4.78e-07	199	154	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	NRIP1 PHACTR2 ATRX GATA3 HIPK2 EIF6 GOLGA4 ZNF292	4.78e-07	199	154	8	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 DCDC1 MUC16 LRRIQ1 PTPRN2 SPAG17 WDR49	9.80e-07	151	154	7	8216462e723fec2797387929dde095370947e10a
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 LRGUK LRRIQ1 KIF19 CEP126 SPAG17 WDR49	9.80e-07	151	154	7	81cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 LRGUK LRRIQ1 KIF19 CEP126 SPAG17 WDR49	9.80e-07	151	154	7	9cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 LRGUK LRRIQ1 KIF19 CEP126 SPAG17 WDR49	1.17e-06	155	154	7	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 LRGUK LRRIQ1 KIF19 CEP126 SPAG17 WDR49	1.17e-06	155	154	7	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	PCLO MUC16 RNF17 ZNF750 LRRIQ1 FGD1 SPAG17	1.22e-06	156	154	7	10d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 E2F7 LRRIQ1 ALMS1 CEP295 SPAG17 WDR49	1.27e-06	157	154	7	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	2.08e-06	169	154	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DCDC1 MAP1B MUC16 LRRIQ1 KIF19 CEP126 SPAG17	2.34e-06	172	154	7	187ae91148d293537afc77e10da2b64302322224
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 PHACTR2 SIRPA PPARD LPCAT2 PRPF40B C3orf70	2.34e-06	172	154	7	1627fa7035b0e0bbc82a1c0f000d8231254c680a
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 PHACTR2 SIRPA PPARD LPCAT2 PRPF40B C3orf70	2.34e-06	172	154	7	574ebdf36e45222bcd907cd2c2ee7ff50ed4573a
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 KIF19 SPAG17 WDR49	2.93e-06	178	154	7	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHACTR2 MAP1B GIN1 LMBR1 AKAP12 PTPRB NIM1K	3.04e-06	179	154	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JCAD REEP1 PCLO CMYA5 AKAP12 USP31 MID1	3.04e-06	179	154	7	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCDC1 HIPK2 CCDC198 LRRIQ1 TMEM132D SPAG17 SDC2	3.28e-06	181	154	7	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	3.40e-06	182	154	7	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	21-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	E2F7 EPB41L3 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	3.40e-06	182	154	7	6e35892fa959ee31591850ded8f1088195ddeb01
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 DCDC1 MUC16 LRRIQ1 KIF19 CEP126 SPAG17	3.78e-06	185	154	7	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	3.78e-06	185	154	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DCDC1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	3.92e-06	186	154	7	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 KIF19 SPAG17 WDR49	4.06e-06	187	154	7	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 KIF19 SPAG17 WDR49	4.21e-06	188	154	7	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 KIF19 CEP126 SPAG17	4.21e-06	188	154	7	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 KIF19 CEP126 SPAG17	4.36e-06	189	154	7	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COBLL1 PCLO SHTN1 LRRIQ1 TMEM132D ZNF804B WDR49	4.36e-06	189	154	7	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	4.36e-06	189	154	7	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	4.36e-06	189	154	7	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	REEP1 PCLO SIRPA CMYA5 AKAP12 USP31 WDR49	4.51e-06	190	154	7	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	E2F7 ECT2 LRRIQ1 ALMS1 TPX2 CEP295 WDR49	4.51e-06	190	154	7	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DNAH3 DCDC1 MAP1B LRRIQ1 KIF19 CEP126 SPAG17	4.51e-06	190	154	7	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 WAPL ATRX ASH1L KMT5B UBTF TMF1	4.67e-06	191	154	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 WAPL ATRX ASH1L KMT5B UBTF TMF1	4.67e-06	191	154	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	REEP1 PCLO HIPK2 CMYA5 AKAP12 USP31 LRRIQ1	4.83e-06	192	154	7	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 DCDC1 MUC16 LRGUK LRRIQ1 CEP126 SPAG17	4.83e-06	192	154	7	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	5.00e-06	193	154	7	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN VSTM1	5.00e-06	193	154	7	52f5b0fbb8ca706206c65e7edbb1ddbd380aebae
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	5.00e-06	193	154	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	(7)_MNP-(7)_DC_1\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	BCL2L14 CTNNAL1 SHTN1 DST MKI67 LRRCC1 SDC2	5.17e-06	194	154	7	8dbe0188e2af6f14b3b44e5213fbdd581128082f
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTNNAL1 MAP1B CMYA5 AKAP12 DST CEP295 CHD6	5.17e-06	194	154	7	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COBLL1 PCLO SHTN1 CCDC198 LRRIQ1 TMEM132D ZNF804B	5.17e-06	194	154	7	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WAPL ATRX ASH1L NSD1 AKAP12 PTPRB TMF1	5.17e-06	194	154	7	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	E2F7 RCC2 LRRIQ1 ALMS1 CEP295 CEP126 WDR49	5.17e-06	194	154	7	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast\|World / Lineage, cell class and subclass	HEMGN CPOX ECT2 TPX2 MKI67 LRRCC1 CA1	5.17e-06	194	154	7	008bb0072f414a48d052429101bdc990ee4f80c2
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F7 SIRPA SHTN1 ECT2 PTPN12 TPX2 MKI67	5.17e-06	194	154	7	effd38e51062b225ecabc7e1c50154e65495d559
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DCDC1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	5.35e-06	195	154	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DCDC1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	5.35e-06	195	154	7	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DCDC1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	5.53e-06	196	154	7	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	Sepsis-URO-Lymphocyte-T/NK-Treg\|URO / Disease, condition lineage and cell class	CTNNAL1 GATA3 PSD3 HEMGN ABCA10 TET1 ABCD2	5.53e-06	196	154	7	8812d7365fb2b33feff93782d60776e932499a43
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NYAP2 REEP1 MAP2 EPB41L3 SHTN1 DST GOLGA8B	5.72e-06	197	154	7	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DCDC1 LRGUK LRRIQ1 CEP126 SPAG17 WDR49	5.72e-06	197	154	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B ABCA10 AKAP12 LPCAT2 VCAN C3orf70 LRRCC1	5.72e-06	197	154	7	6806ec223e542f0475303698eb78c1cc527f5c6b
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DCDC1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	5.72e-06	197	154	7	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DCDC1 LRRIQ1 KIF19 CEP126 SPAG17 WDR49	5.72e-06	197	154	7	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	erythropoietic-Polychromatic_Erythroblast\|World / Lineage and Cell class	CTNNAL1 HEMGN CPOX TPX2 MKI67 LRRCC1 CA1	5.72e-06	197	154	7	604fcbf47f073c2af344e1b16b615a78ef838dc9
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 DCDC1 ZNF473 E2F7 LRRIQ1 KIF19 WDR49	5.91e-06	198	154	7	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN SDC2	5.91e-06	198	154	7	94e2567f057b2c455a9656b121321a28e7cb1d2b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ATRX MAP1B MAP2 SHTN1 VCAN ZNF91 ZNF292	5.91e-06	198	154	7	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 PTPN12 LPCAT2 VCAN SDC2	5.91e-06	198	154	7	7b61f427ed5ca8ad563e5f112fba950a24c9d956
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN SDC2	5.91e-06	198	154	7	f3a12a7e23bb4ff6e82fee675dbc090d99587f69
ToppCell	mLN-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	PCLO E2F7 ECT2 TRDC TPX2 MKI67 WDR49	6.11e-06	199	154	7	c81a194f8c2f120c6c4d74857912865a3c2fe1e7
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN SDC2	6.11e-06	199	154	7	c4fc638a8dad3a9b77634e8912a9326c8a2f11f5
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN SDC2	6.11e-06	199	154	7	97af159fa3a5533ec3d45331fb80c6da8a715aa5
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 DCDC1 ZNF473 MUC16 LRRIQ1 SPAG17 WDR49	6.11e-06	199	154	7	542ec45c931b40738df1f3777b00c83be33a514a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	REEP1 E2F7 EPB41L3 ECT2 TPX2 MKI67 DNA2	6.11e-06	199	154	7	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	(5)_Dendritic_cell\|World / shred on Cell_type and subtype	SIRPA EPB41L3 SHTN1 LPCAT2 TPX2 MKI67 SDC2	6.11e-06	199	154	7	495de74a918c5c625a2d0ef120fe4162d4ce6e76
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN SDC2	6.11e-06	199	154	7	6783d571d28eac891fcc70380f176b53f35c88ba
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	ECT2 AKAP12 DST VCAN TPX2 MKI67 HERC5	6.11e-06	199	154	7	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 LPCAT2 OTOF VCAN HERC5	6.11e-06	199	154	7	d3f77acb36ac7c56a47ca98b695f46ae5b9ecd12
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 DCDC1 ZNF473 MUC16 LRRIQ1 SPAG17 WDR49	6.11e-06	199	154	7	2498237b9e895ca4826a3378d9d40989968df72b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NRIP1 SIRPA EPB41L3 SHTN1 LPCAT2 VCAN SDC2	6.11e-06	199	154	7	697a9a58c0cdb77222700d029873355d37f6ab28
ToppCell	(1)_T_cell-(18)_cycling_gd_T\|(1)_T_cell / shred on Cell_type and subtype	ATRX ECT2 TRDC AKAP12 TPX2 MKI67 WDR49	6.11e-06	199	154	7	9369d0e4efe809e3e8757294ebebba5a47b30528
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATRX PSD3 ABCA10 AKAP12 DST VCAN CRYBG3	6.11e-06	199	154	7	615f20bf136dfef53b072667cf0e4df6a1017e05
Drug	Clorgyline	NRIP1 ATRX COBLL1 TBC1D8B DST TMF1 POLK GOLGA4 ZNF292	1.88e-06	168	151	9	ctd:D003010
Drug	Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A	DNAH3 REEP1 MAP2 DUSP1 PCLO CUL9 ZNF750 MINAR1 HERC5	4.54e-06	187	151	9	5294_UP
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A	KANSL1L PHACTR2 REEP1 HIPK2 PPARD CHML KAT8 VCAN SLC16A7	5.17e-06	190	151	9	2465_DN
Drug	monastrol; Down 200; 100uM; PC3; HG-U133A	NRIP1 CTNNAL1 ZNF473 HIPK2 CPOX KMT5B KAT8 SLC16A7 SDC2	7.52e-06	199	151	9	668_DN
Disease	Colorectal Carcinoma	DNAH3 PMS2 MAP1B MAP2 ABCA10 AKAP12 CDKL5 MLH3 PTPRN2 CCNB3 TPX2 MKI67 ETAA1 SPAG17 ABCD2 WDR49 ZNF292	9.69e-08	702	148	17	C0009402
Disease	free cholesterol to total lipids in large LDL percentage	PDXDC1 NYAP2 COBLL1 PSD3 POLK	3.62e-05	74	148	5	EFO_0022280
Disease	cleft lip	JCAD NSD1 MUC16 CCDC168 SHTN1 DST TMEM132D SDC2	9.83e-05	284	148	8	EFO_0003959
Disease	triglyceride measurement, body mass index	PDXDC1 NYAP2 COBLL1	1.13e-04	19	148	3	EFO_0004340, EFO_0004530
Disease	polyunsaturated fatty acids to total fatty acids percentage	PDXDC1 NYAP2 COBLL1 PSD3	1.17e-04	50	148	4	EFO_0022303
Disease	triglycerides to total lipids in large LDL percentage	PDXDC1 NYAP2 COBLL1 POLK	1.26e-04	51	148	4	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	PDXDC1 NYAP2 COBLL1 PSD3	1.26e-04	51	148	4	EFO_0022302
Disease	lymphocyte count	JCAD NRIP1 NYAP2 COBLL1 GATA3 PSD3 NSD1 LMBR1 PPARD CHML TDRD1 LAX1 NUFIP1 BNC1 PTPN12 ALMS1 TSBP1 ATAD2B PGBD2	1.39e-04	1464	148	19	EFO_0004587
Disease	free cholesterol to total lipids in small LDL percentage	PDXDC1 NYAP2 COBLL1 PSD3	1.47e-04	53	148	4	EFO_0022286
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	PDXDC1 NYAP2 COBLL1 PSD3	1.82e-04	56	148	4	EFO_0022316
Disease	cholesterol to total lipids in large LDL percentage	PDXDC1 NYAP2 COBLL1 POLK	1.82e-04	56	148	4	EFO_0022235
Disease	triglycerides to total lipids in small LDL percentage	PDXDC1 NYAP2 COBLL1 PSD3	2.23e-04	59	148	4	EFO_0022337
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.23e-04	59	148	4	EFO_0022260
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.38e-04	60	148	4	EFO_0021898
Disease	cholesterol to total lipids in IDL percentage	PDXDC1 NYAP2 COBLL1 POLK	2.38e-04	60	148	4	EFO_0022233
Disease	total lipids in chylomicrons and extremely large VLDL measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.70e-04	62	148	4	EFO_0022306
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.70e-04	62	148	4	EFO_0022263
Disease	free cholesterol to total lipids in medium LDL percentage	PDXDC1 NYAP2 COBLL1 PSD3	2.88e-04	63	148	4	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.88e-04	63	148	4	EFO_0022292
Disease	cholesteryl esters to total lipids in medium VLDL percentage	PDXDC1 NYAP2 COBLL1 POLK	3.06e-04	64	148	4	EFO_0022253
Disease	creatinine measurement, glomerular filtration rate	DCDC1 EPB41L3 PTPN12 ALMS1 PIP5K1B	3.17e-04	117	148	5	EFO_0004518, EFO_0005208
Disease	body fat percentage, fasting blood insulin measurement	NYAP2 COBLL1	3.70e-04	6	148	2	EFO_0004466, EFO_0007800
Disease	triglycerides to total lipids in very small VLDL percentage	PDXDC1 NYAP2 COBLL1 PSD3	4.08e-04	69	148	4	EFO_0022341
Disease	white matter volume measurement	RIPK1 ETF1 ZNF292	5.51e-04	32	148	3	EFO_0008320
Disease	free cholesterol to total lipids in small VLDL percentage	PDXDC1 NYAP2 COBLL1 PSD3	5.60e-04	75	148	4	EFO_0022287
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	PDXDC1 NYAP2 COBLL1 PSD3	6.50e-04	78	148	4	EFO_0022187
Disease	age at menopause	SYCP2L NYAP2 ASH2L BNC1 ETAA1 CHD6 DNA2	8.59e-04	302	148	7	EFO_0004704
Disease	Lynch Syndrome	PMS2 MLH3	8.79e-04	9	148	2	C4552100
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	PDXDC1 NYAP2 COBLL1 PSD3	9.38e-04	86	148	4	EFO_0008595, EFO_0020945
Disease	Neurodevelopmental Disorders	ASH1L CDKL5 KMT5B ZNF292	1.26e-03	93	148	4	C1535926
Disease	free cholesterol to total lipids in very small VLDL percentage	PDXDC1 NYAP2 PSD3	1.32e-03	43	148	3	EFO_0022290
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	PDXDC1 NYAP2 COBLL1 PSD3	1.36e-03	95	148	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	PDXDC1 NYAP2 COBLL1 PSD3	1.41e-03	96	148	4	EFO_0004530, EFO_0008317, EFO_0008596
Disease	motor neuron disease (implicated_via_orthology)	VAPA VPS54	1.60e-03	12	148	2	DOID:231 (implicated_via_orthology)
Disease	Neuroblastoma	ATRX GATA3 CHD6	1.71e-03	47	148	3	C0027819
Disease	phosphatidylethanolamine measurement	PDXDC1 BCL2L14 SYCP2L PHACTR2 CMYA5	1.84e-03	173	148	5	EFO_0010228
Disease	N-acetylglutamine measurement	PSD3 ALMS1	1.88e-03	13	148	2	EFO_0800017
Disease	blood phosphate measurement	BCL2L14 DCDC1 GATA3 NSD1 PIP5K1B	1.89e-03	174	148	5	EFO_0010972
Disease	urate measurement	SYCP2L DNAH3 NYAP2 DCDC1 ASH1L PSD3 NSD1 EPB41L3 PHF21A KMT5B TMF1 PIP5K1B	1.90e-03	895	148	12	EFO_0004531
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.03e-03	106	148	4	EFO_0008317, EFO_0008596
Disease	triglycerides to total lipids in medium LDL percentage	PDXDC1 NYAP2 POLK	2.04e-03	50	148	3	EFO_0022334
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.25e-03	109	148	4	EFO_0004639, EFO_0008317, EFO_0008596
Disease	amino acid measurement	NYAP2 DCDC1 COBLL1 PSD3 E2F7 PTPRB ALMS1 PTPRG PTPRN2 VCAN	2.29e-03	678	148	10	EFO_0005134
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.32e-03	110	148	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.32e-03	110	148	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	PDXDC1 NYAP2 COBLL1 PSD3	2.32e-03	110	148	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	triglycerides to total lipids in very large VLDL percentage	PDXDC1 NYAP2 COBLL1	2.41e-03	53	148	3	EFO_0022340
Disease	Heschl's gyrus morphology measurement	COBLL1 VPS8 ZNF804B	2.41e-03	53	148	3	EFO_0005852
Disease	cholesteryl esters to total lipids in very large VLDL percentage	PDXDC1 NYAP2 COBLL1	2.41e-03	53	148	3	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	PDXDC1 NYAP2 COBLL1	2.54e-03	54	148	3	EFO_0022244
Disease	reticulocyte measurement	VAPA NYAP2 COBLL1 ASH1L HEMGN SIRPA EIF6 NUFIP1 AZIN1 ATAD2B TPX2 EPB41 CA1	2.55e-03	1053	148	13	EFO_0010700
Disease	triglycerides in LDL measurement	NYAP2 COBLL1 PSD3	2.82e-03	56	148	3	EFO_0022320
Disease	cholesteryl esters to total lipids in large VLDL percentage	PDXDC1 NYAP2 COBLL1	2.82e-03	56	148	3	EFO_0022250
Disease	Cardiovascular Abnormalities	KAT8 ZNF292	2.86e-03	16	148	2	C0243050
Disease	focal segmental glomerulosclerosis	CCDC7 ALMS1	2.86e-03	16	148	2	EFO_0004236
Disease	leptin measurement, type 2 diabetes mellitus	NYAP2 COBLL1	2.86e-03	16	148	2	EFO_0005000, MONDO_0005148
Disease	body mass index, type 2 diabetes mellitus	NYAP2 COBLL1	2.86e-03	16	148	2	EFO_0004340, MONDO_0005148
Disease	free cholesterol to total lipids in medium VLDL percentage	PDXDC1 NYAP2 COBLL1	2.97e-03	57	148	3	EFO_0022284
Disease	low density lipoprotein particle size measurement	NYAP2 COBLL1 POLK	3.12e-03	58	148	3	EFO_0008593
Disease	omega-6 polyunsaturated fatty acid measurement	PDXDC1 NYAP2 COBLL1 PSD3 PPARD	3.23e-03	197	148	5	EFO_0005680
Disease	body fat percentage, type 2 diabetes mellitus	NYAP2 COBLL1	3.23e-03	17	148	2	EFO_0007800, MONDO_0005148
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	JCAD SIRPA	3.23e-03	17	148	2	EFO_0010543, EFO_0010544
Disease	cholesteryl esters to total lipids in large HDL percentage	NYAP2 COBLL1 PSD3	3.27e-03	59	148	3	EFO_0022248
Disease	free cholesterol to total lipids in medium HDL percentage	PDXDC1 NYAP2 COBLL1	3.43e-03	60	148	3	EFO_0022282
Disease	free cholesterol in HDL measurement	PDXDC1 NYAP2 COBLL1	3.60e-03	61	148	3	EFO_0022264
Disease	Feeding difficulties	KAT8 ZNF292	3.63e-03	18	148	2	C0232466
Disease	BMI-adjusted fasting blood insulin measurement	NYAP2 COBLL1	3.63e-03	18	148	2	EFO_0008037
Disease	triglycerides in medium LDL measurement	NYAP2 COBLL1 PSD3	3.77e-03	62	148	3	EFO_0022322
Disease	triglycerides to total lipids in very large HDL percentage	PDXDC1 NYAP2 COBLL1	3.77e-03	62	148	3	EFO_0022339
Disease	free cholesterol in very large HDL measurement	PDXDC1 NYAP2 COBLL1	3.77e-03	62	148	3	EFO_0022273
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	PDXDC1 NYAP2 COBLL1 PSD3	3.90e-03	127	148	4	EFO_0008595, EFO_0020947
Disease	triglycerides to total lipids in IDL percentage	PDXDC1 NYAP2 COBLL1	3.94e-03	63	148	3	EFO_0022329
Disease	triglycerides to total lipids in medium VLDL percentage	PDXDC1 NYAP2 COBLL1	3.94e-03	63	148	3	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	PDXDC1 NYAP2 COBLL1	3.94e-03	63	148	3	EFO_0022239
Disease	body mass index, high density lipoprotein cholesterol measurement	NYAP2 COBLL1	4.04e-03	19	148	2	EFO_0004340, EFO_0004612
Disease	squamous cell carcinoma (is_marker_for)	RIPK1 DUSP1	4.04e-03	19	148	2	DOID:1749 (is_marker_for)
Disease	triglycerides in small LDL measurement	NYAP2 COBLL1 PSD3	4.30e-03	65	148	3	EFO_0022323
Disease	creatinine measurement	BCL2L14 HINT1 NYAP2 DCDC1 NSD1 EPB41L3 CDKL5 PTPN12 ALMS1 ZNF592 PIP5K1B ZNF396	4.47e-03	995	148	12	EFO_0004518
Disease	total lipids in very large HDL measurement	PDXDC1 NYAP2 COBLL1	4.49e-03	66	148	3	EFO_0022312
Disease	magnesium measurement	PHACTR2 DCDC1 CCDC168	4.49e-03	66	148	3	EFO_0004845
Disease	phospholipids in very large HDL measurement	PDXDC1 NYAP2 COBLL1	4.49e-03	66	148	3	EFO_0022298
Disease	calcium measurement	BCL2L14 COBLL1 GATA3 PSD3 TRMT10C PTPRN2 UBTF PIP5K1B POLK	4.54e-03	628	148	9	EFO_0004838
Disease	very low density lipoprotein particle size measurement	PDXDC1 NYAP2 COBLL1 PSD3	4.59e-03	133	148	4	EFO_0008594
Disease	cholesterol to total lipids in very small VLDL percentage	PDXDC1 NYAP2 COBLL1	4.68e-03	67	148	3	EFO_0022245
Disease	triglycerides in very small VLDL measurement	NYAP2 COBLL1 PSD3	4.88e-03	68	148	3	EFO_0022144
Disease	fatty acid measurement, linoleic acid measurement	PDXDC1 NYAP2 COBLL1	4.88e-03	68	148	3	EFO_0005110, EFO_0006807
Disease	triglycerides to phosphoglycerides ratio	PDXDC1 NYAP2 COBLL1	4.88e-03	68	148	3	EFO_0022327
Disease	platelet component distribution width	JCAD NRIP1 NYAP2 COBLL1 HEMGN SIRPA ATAD2B PIP5K1B POLK EPB41	4.90e-03	755	148	10	EFO_0007984
Disease	triglyceride measurement, body fat percentage	NYAP2 COBLL1	4.93e-03	21	148	2	EFO_0004530, EFO_0007800

Protein segments in the cluster

Peptide	Gene	Start	Entry
DSDKDLKATISHVSP	PTPRG	401	P23470
KPHSVSLNDTETRKL	VAPA	161	Q9P0L0
ELIDKSETPHVSVSK	TDRD1	651	Q9BXT4
EITELPASAHKNKSK	TTF1	206	Q15361
PTHEDLTKNKERTSE	EPB41	61	P11171
KEVNDSKTTHIDIPR	ASH1L	631	Q9NR48
SAHDVSPEKVTSALK	LINC01551	101	Q86U37
TSDKNTIIDIDHTKP	VCAN	2571	P13611
TTQLKSHPETDKEFL	CCDC7	1166	Q96M83
ASSHVKAPEDKIESL	CRYBG3	541	Q68DQ2
SKILNSDSVKPHDVV	CRYBG3	1341	Q68DQ2
KQHIPDAKLTTESEE	ABCA10	641	Q8WWZ4
ESESHSKNGAKVELP	ABCD2	446	Q9UBJ2
SKLSEDLNTIPEVHK	AZIN1	326	O14977
LETSLSHTEEKQDPK	ALPK2	1761	Q86TB3
TEKPEETLKREQSHA	AKAP12	236	Q02952
TSSTPKEKESVELHD	AFF2	651	P51816
SPSSEHDVLKEAVLK	AASS	771	Q9UDR5
NCPDAITKKEDSTHL	BNC1	306	Q01954
LKISTVHIPDDQKTE	ALMS1	1996	Q8TCU4
QGHVPVASSSKKDEE	BCL2L14	191	Q9BZR8
DKKVSSVSHENPTEV	DOP1A	571	Q5JWR5
DALISKESNTPKIDH	C3orf70	166	A6NLC5
EEKQETKSTDGQEPH	COBLL1	476	Q53SF7
KNEKELHSEPSSNET	FAM204A	111	Q9H8W3
KHTTQEEVSILKEPS	CCNB3	441	Q8WWL7
KEPSVDTEAHFKETL	CCNB3	846	Q8WWL7
VDKAEKSLKQTPHSE	ASH2L	526	Q9UBL3
CEHSKPLKQEEATAT	MKRN4P	141	Q13434
SEESKNLESPEKHLQ	CHML	641	P26374
DHKPKSSTAAQEVKT	RCC2	466	Q9P258
TQLSTDTKKDKHPDP	SEPTIN14P20	36	C0HM01
SDLKASTLVHKPQSD	NSD1	731	Q96L73
KKHTADENPDKSTLE	ECT2	611	Q9H8V3
KKSEHPESSLSSEEE	PTPRN2	426	Q92932
LDKSETKFPNHKETD	KIAA1107	536	Q9UPP5
HKIPTTSEDIKDTEK	MUC16	6571	Q8WXI7
HKKATDSLPVVETKE	GJC3	241	Q8NFK1
SKKDLGSDSPIQTDH	DCDC1	511	M0R2J8
TSEPATTKQHKFEDL	PTPRB	1041	P23467
LSHSEEFIKKEPLSD	KANSL1L	126	A0AUZ9
SHPADSVVSVLNKEK	SLC25A3	281	Q00325
EEEEQKHAPTSTVSK	HIPK2	896	Q9H2X6
TDEKSSHLPTEVIEK	MAP1B	1341	P46821
SSKDPNHSTALKVIE	NGRN	181	Q9NPE2
EENTEEKSKSHLVQP	GOLGA4	1901	Q13439
KKVTEESDKHTVQDP	DST	6336	Q03001
PTTAALEKEHEAITK	KAT8	161	Q9H7Z6
KLHLPNTSRDSETAK	LMBR1	466	Q8WVP7
EDQSKEKPETSTENH	ATAD2B	1311	Q9ULI0
KQFAKIEESTPVHDS	KMT5B	621	Q4FZB7
SKDSISREEKEHPAA	JCAD	1321	Q9P266
PTLKCSIADKHSEEN	FSIP2	2116	Q5CZC0
EAKTSAPEEQKHDLL	PCLO	1251	Q9Y6V0
TLADEKSEKKTQPHE	PCLO	1426	Q9Y6V0
DIPSSKDHKEKSEFV	PCLO	1486	Q9Y6V0
KHEKTENGVIPTSDS	MLH3	926	Q9UHC1
HELSDISELPEKSDK	PDZD4	451	Q76G19
DKSSLKSDPEGENIH	PDXDC1	531	Q6P996
LDHSLKEKEEETPQN	PIP5K1B	276	O14986
NEADKTPLKSSHENE	CYLC1	156	P35663
PSLEKQTVKSHTETD	PHF21A	326	Q96BD5
RESEPLSKSKHSEDV	SLC16A7	446	O60669
KDVPSSNIGHVEDKT	LAX1	311	Q8IWV1
KHRTEKSESDQPVSL	NRIP1	446	P48552
ATTADVKTSHLKPEA	LRGUK	611	Q96M69
TQTTHTDKVPGDEDK	MKI67	2141	P46013
AEDKKENTENHSETP	PHACTR2	136	O75167
PKKHISQISVAEDDD	HINT1	56	P49773
EPAEKSTEELKVRSH	NYAP2	536	Q9P242
PLDKTGHVKDTNQED	PAXBP1	161	Q9Y5B6
PKHLSETSTLKEEEN	NIM1K	341	Q8IY84
IQEIAEPKDLSTKTH	HEMGN	301	Q9BXL5
EPKDLSTKTHQESAE	HEMGN	306	Q9BXL5
EDPIHKDTTANEKLE	LRRIQ1	1611	Q96JM4
ELFPSKTAHVTDQKE	ETAA1	401	Q9NY74
VHPKTSIEDQDELSS	EIF6	161	P56537
PVKVSSSEELKLESH	HERC5	341	Q9UII4
DSSENLSEIPLSHKE	KIF19	756	Q2TAC6
SNKVSPEKHEESTSD	LPCAT2	526	Q7L5N7
KKVHDSLEDFPKNSS	GATA3	376	P23771
IPNTKDFDSSEDEKH	ATRX	841	P46100
KEHVLKLEPLTSDDS	IGSF22	121	Q8N9C0
IEESQDAPDHSKFKT	E2F7	316	Q96AV8
ETLTLHPSSKIAKEN	CTNNAL1	486	Q9UBT7
SHIADKVSEVPANTK	DNAH3	706	Q8TD57
KSIPVEDNHKADISS	DUSP1	221	P28562
EKTAEDKPSSHDVKT	CHD6	2566	Q8TD26
DKPSSHDVKTDTLAE	CHD6	2571	Q8TD26
PVDIKTSETKHDTSL	CA1	31	P00915
IDSALPSALSKNDHK	CEP126	171	Q9P2H0
KALHSDQTVKLPDVS	CMYA5	1826	Q8N3K9
EKVEVSSNPHRASKL	CUL9	1171	Q8IWT3
QLPDTETHSISKAKA	CCDC168	851	Q8NDH2
LHSPRKKDTQVLSES	CCDC168	6706	Q8NDH2
EPQSDLEELKHENKS	GOLGA8B	361	A8MQT2
KKTLQSTPRNDDHDL	CCDC198	191	Q9NVL8
SPENISHSEQLKEKE	CDKL5	761	O76039
KLNKSESAEHTIPSL	CEP295	1631	Q9C0D2
PLELKTGKESNSIEH	DNA2	296	P51530
TKSPEETDKEKVHLS	SDC2	101	P34741
HSPSENSKEAEILEV	CPOX	431	P36551
EQKPHFESSTVKTET	EPB41L3	941	Q9Y2J2
IKTPHKANETDEDDI	OTOF	386	Q9HC10
EKLEEISPTSDSHEK	FAM149B1	31	Q96BN6
KSKEISSPVDLEKHE	MINAR1	436	Q9UPX6
DKKHSDRPELLQSET	RTL4	216	Q6ZR62
SAPEEAKSKRHISIQ	TRMT1L	71	Q7Z2T5
KKTETETSLHPLLQE	PPARD	421	Q03181
TSLDEKVVSIHQDPK	TMEM132D	736	Q14C87
AKTAQEKDSLITPHV	RGPD2	1456	P0DJD1
TKISPLIDDHSSLEK	GIN1	491	Q9NXP7
HGSPDSKDAQKSLEL	FGD1	536	P98174
DHSRVKLTLKTPSQD	PTPN12	71	Q05209
STHEPQTKDQVAEKD	SHTN1	586	A0MZ66
DGQPAVSKSHDLKVS	SIRPA	336	P78324
THQGENTKEDPSLKD	VPS8	1101	Q8N3P4
FVHPTLSSKEKEIDD	REEP1	91	Q9H902
TSLKEKEHNKEPDSS	SREK1	456	Q8WXA9
KEHNKEPDSSVSKEV	SREK1	461	Q8WXA9
EHLNDVNAKPTEKSD	RIPK1	196	Q13546
SHSQELLKIKTEPVD	PLAGL2	241	Q9UPG8
DTSDLNLDFKPHKVS	SPAG17	1951	Q6Q759
EVKSETEPHFILKSS	TET1	1811	Q8NFU7
DGQSSEKAPEVSHIK	ABRA	91	Q8N0Z2
ASDPHIEDLKSQELS	PGBD2	126	Q6P3X8
LDNSHSLSEKSLEVP	RNF17	1111	Q9BXT8
LSKKSEINLAATHEP	ZNF750	516	Q32MQ0
SDQKAVIHSKSSPEI	UHRF1BP1L	1241	A0JNW5
KSQRPEEEVKSSLHE	TMF1	121	P82094
KDTHLTKEKEVNISP	ZNF804B	271	A4D1E1
TKEKEVNISPSHLES	ZNF804B	276	A4D1E1
INSDSESDKEEKPQH	NUFIP1	336	Q9UHK0
LHVSKPANEKEAESA	TBC1D8B	936	Q0IIM8
SSLKHSEDEEKPKIV	SYCP2L	616	Q5T4T6
VASVTKEDQPGHTKD	ZNF592	296	Q92610
VERDESSSKKSHTPE	MID1	506	O15344
PTEHSLLNKKNKDDS	WDR49	556	Q8IV35
KEVNKLSEHERSISP	POLK	236	Q9UBT6
TVSLKKLEVHSNDPD	ZNF292	2691	O60281
ELIKDAPTTQHDKSG	WAPL	1056	Q7Z5K2
LEDSNSHSLKKDPVV	TEX13C	766	A0A0J9YWL9
HKSNSPESETDPEEK	PRPF40B	791	Q6NWY9
KSDSSFHLEKPSVQL	TRAV18	86	A0A075B6X5
KRTSHSKLPEQEAAE	VSTM1	171	Q6UX27
DLKHAALVSQPETTK	MAP2	191	P11137
EHVDSQEKAPKTDDS	PMS2	531	P54278
TLESHETEEPAAKKR	TRMT6	476	Q9UJA5
STLANHKITHTEEKP	ZNF91	671	Q05481
EVKTDSTDHVKPKET	TRDC	86	B7Z8K6
VVHDTSTELLSPKKD	ZMYM1	326	Q5SVZ6
EQLVTKDPASAKHSL	USP31	1291	Q70CQ4
SPDHSDEKLIEKENQ	TEX15	1176	Q9BXT5
VDKHGDDQPDSSSLK	TRAPPC10	1191	P48553
KHPELNISEEGITKS	UBTF	266	P17480
PHDEDIKTTNVKSAS	ZNF396	186	Q96N95
NSVESLKSAHIKEPE	TSBP1	261	Q5SRN2
ESTEEKANGTHPKTI	PSD3	751	Q9NYI0
LTSTEKSHVDLFPKD	TRMT10C	271	Q7L0Y3
KDQPVISKHETEENS	TBPL2	111	Q6SJ96
THDKSRTDLEQVPKI	VPS54	151	Q9P1Q0
HNVSEKTLTPAKSKE	ZNF473	171	Q8WTR7
HQDTAEKNASSPEKA	TPX2	176	Q9ULW0
LTPEQEKDKSHFTDK	ETF1	346	P62495
PKTEIIKVDQSHSED	LRRCC1	406	Q9C099